City
Epaper

CRISPR-based diagnostic test to detect ulcer, gastric cancer-causing bacteria

By IANS | Updated: December 27, 2024 17:15 IST

New Delhi, Dec 27 A team of Indian scientists, including from CSIR-Institute of Genomics and Integrative Biology (IGIB) ...

Open in App

New Delhi, Dec 27 A team of Indian scientists, including from CSIR-Institute of Genomics and Integrative Biology (IGIB) and AIIMS has developed a new method using CRISPR-based diagnostic test FELUDA for detecting H. pylori bacteria, said the Ministry of Science and Technology on Friday.

Infections with H. pylori are known to affect over 43 per cent of the world’s population. It can cause a wide range of gastrointestinal disorders, including peptic ulcers, gastritis, dyspepsia, and even gastric cancer.

In the study, the team found a way to develop FELUDA as a point-of-care diagnostic service at a minimal cost for the detection of H. pylori and its mutations in patients having indigestion. They included patients from rural areas of India, with minimal or no access to diagnostic laboratories. FELUDA is an acronym for FnCas9 Editor Linked Uniform Detection Assay.

Gastric biopsy samples from dyspeptic (indigestion) patients were tested both by in vitro cleavage studies and lateral flow-based test strip assays (FELUDA).

The results showed the potential of en31-FnCas9 to successfully detect the presence and identify the 23S rDNA mutation status of H. pylori in gastric biopsy samples from dyspeptic (indigestion) patients.

The paper, published in the Microchemical Journal, highlights the significance of sequencing-free molecular diagnosis in detecting H. pylori and its antibiotic-resistance mutations. The findings stress the need for tailored treatment plans to address global public health concerns associated with antibiotic resistance and gastric cancer risks.

The integration of en31-FnCas9-based detection with lateral flow assay (FELUDA) demonstrated rapid detection of H. pylori infection and its mutation status. This can boost its diagnostic potential in clinical settings.

“Therefore, integration of novel diagnostic strategies as cost-effective diagnostic tools to detect the presence of H. pylori in human samples, as well as the identification of the antibiotic susceptibility is crucial for its rapid eradication,” the team said.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

MumbaiMumbai: Fire Breaks Out at Anupama Serial Set in Goregaon Film City, 5 Fire Tenders at Spot

EntertainmentAnupam walks on streets of NY with De Niro: Never in my wildest dreams I’d ever thought

MumbaiMumbai: 23-Year-Old Caretaker Arrested for Theft At Employer's Home in Dindoshi

Entertainment'The Walking Dead: Daryl Dixon' season 3 gets premiere date, check out new teaser

BusinessTop 5 states to contribute half of capex in FY26, UP & Gujarat biggest contributor: Report

Technology Realted Stories

TechnologyImported seafood increasing resistance to colistin, a potent antibiotic: Study

TechnologyNifty, Bank Nifty show bullish pattern, hint at possible breakout: Report

TechnologySix of India’s top 10 firms add Rs 1.62 lakh crore in market value this week

TechnologyApple expands Audio Mix feature beyond Photos App with iOS 26

TechnologyIndia's power capacity jumps by 56 pc from 305 GW to 476 GW in 10 years